Martine A Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS, sold UTHR on Jul 10, 2026
Data as of Oct 16
▼ SELL$863K1,578 shares at $547.17Martine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp
- Traded
- Jul 10, 2026
- Disclosed
- Jul 13, 2026
- Filed
- 3 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
UTHR since disclosure
−0.5%
after the sale
Similar stocks (XLV) since disclosure
+9.5%
XLV — its sector index fund
Change in closing price from Jul 13, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$219Kdisclosed Jul 13 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$198Kdisclosed Jul 13 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$367Kdisclosed Jul 13 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$786Kdisclosed Jul 13 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$525Kdisclosed Jul 13 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1Mdisclosed Jul 13 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$324Kdisclosed Jul 13 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$831Kdisclosed Jul 13 · filed 3 days after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$44.3Kdisclosed Jul 13 · filed 3 days after the trade